The 75th PharmChina Fair took place at Shanghai National Exhibition and Convention Center April 18-20, 2016. This Fair is one of the largest national gatherings for the pharmaceutical and healthcare sectors and manufacturers, with a mission of “Pharmaceutical Innovations and Technologies for A Healthy Future”. Over 2000 exhibitors across the Country attended this fair to promote innovation, exchange information, and discuss collaboration. 

ASK Pharm launched 3 brand-new proprietary products at the Fair; they are Esomeprazole Sodium for Injection (奥一明®), Esmolol Hydrochloride for Injection (奥一心®), and Leflunomide Capsule (奥克鲁®). Among these products, Esomeparzole Sodium for Injection is the first generic product approved in China and Leflunomide Capsule the only capsule dosage available in China. The launch of these innovative products by ASK has once again demonstrated our corporate R&D productivity and sustainability; they have also expanded ASK Brand into other drug categories, in addition to ASK’s proprietary leadership in digestive and oncology medicines. The product information was well received by the fair attendees.  

The Chinese pharmaceutical industry is currently in a critical transition stage; the government and regulatory bodies have placed significant emphasis on product variety, healthcare affordability and economy sustainability. ASK Pharm has consistently maintained its leadership in R&D innovation, brand recognition, and corporate reputation for years, and we will continue to contribute to national economic and social development in the future.